Serialization’s interface between the plant floor, the enterprise and the world
Dispense As Written
FDA looks to industry for help in DSCSA compliance
Clinical cold chain vendors go into a deep freeze
Demand for cryogenic logistics propels business growth
Oncology: a new era in therapies; same cost concerns
A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor
Brand enhancement and safety with unit-dose packaging
Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging
Managing supply chains from the cloud
New IT data-science and visualization tools advance supply chain management
Changing the payment paradigm
Policymakers look at alternative payment models in oncology
Specialty pharmacy dynamics
The SP channel continues to grow, with manufacturers looking for more control over access
Laying the foundation for a national system for evidence generation
Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis
Strengthening healthcare and pharmaceutical supply chains is critical for healthcare resiliency
A Conversation with Mark Merritt, Pharmaceutical Care Management Association
2016 Product Security Report
Pharma spends heavily to secure its supply chain, while politicians bring out the re-importation topic
Copay assistance data on the iPad: TrialCard’s new app
Integrating copay programs with multichannel marketing
Vertex’ Orkambi medication package is Compliance Package of the Year
Healthcare Compliance Packaging Council (HCPC) award again goes to PCI Pharma Services
Prescription-drug abuse legislation signed into law
Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) calls for better industry-government coordination
Prepaid cash cards motivate clinical trial patients
Greenphire highlights its support of patient recruitment and retention
IMS 2015 Use of Medicines report: US sales reach $424.8 billion
Double-digit growth (12.2%) for the second year running
More injectables capacity in the US, Germany
Novo Nordisk and Vetter Pharma announce groundbreakings
FDA proposes guidance for biosimilar product labels
Labels will have a combination of reference-product and biosimilar-specific information
Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute
Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians
ZS Associates sharpens focus on pharma-physician interaction
'Customer Experience Tracker' measures success in oncologist interactions
